![\"\"](\"https:\/\/matribhumisamachar.com\/en\/wp-content\/uploads\/2026\/04\/DSC_9490-300x156.jpg\")
<\/p>\n<\/p>\n
Basavatarakam Indo-American Cancer Hospital & Research Institute, commemorates its silver Jubilee on the occasion.<\/strong><\/p>\n \u00a0<\/strong><\/p>\n The Conference is jointly hosted by the International Society for Diseases of the Esophagus & Basavatarakam Indo-American Cancer Hospital & Research Institute.<\/strong><\/p>\n \u00a0<\/strong><\/p>\n Hyderabad, April 10, 2026:<\/strong>\u00a0The prestigious two-day international conference,\u00a0ISDE India Edition 2026<\/strong><\/em>,<\/em><\/strong>\u00a0hosted by the\u00a0International Society for Diseases of the Esophagus<\/strong>\u00a0(ISDE) in association with\u00a0Basavatarakam Indo-American Cancer Hospital & Research Institute<\/strong>\u00a0(BIACH&RI), was inaugurated today by\u00a0Shri Nandamuri Balakrishna<\/strong>, Chairman & Managing Trustee, NBTRMCF, at The Westin Hyderabad, Madhapur. Being held in India for the first time, the conference underscores the country\u2019s growing prominence in esophageal cancer research, innovation, and clinical expertise.<\/p>\n Scheduled on April 10\u201311, the conference has brought together over 150 oncologists from across the globe, including experts from Canada, Singapore, Japan, Australia, and the USA, alongside leading Indian clinicians. The event also coincides with the Silver Jubilee of BIACH & RI, one of India\u2019s premier cancer care institutions.<\/p>\n Speaking on the occasion Chief Guest\u00a0Shri Nandamuri Balakrishna<\/strong>\u00a0said,\u00a0this is a historic occasion, for this is the\u00a0very first Indian Edition of the ISDE<\/strong>, and we are deeply humbled to be your hosts on this landmark stage. What makes this moment even more meaningful is that this year, the\u00a0Basavatarakam Indo-American Cancer Hospital & Research Institute celebrates its Silver Jubilee \u2014 25 years of unwavering commitment to cancer care, research, and academic excellence<\/strong>. Two milestones. One powerful convergence. For a quarter of a century, this institution has stood on a singular belief, that\u00a0world-class cancer treatment must not be a privilege of the few, but an accessible right for every Indian<\/strong>. Our pursuit of research has never been forced or performative, it has been organic, purposeful, and deeply intertwined with our clinical mission. Because when evidence drives practice, patients receive not just treatment, they receive the\u00a0best possible chance at life<\/strong>. This places us at a unique and extraordinary crossroads \u2014 one of the\u00a0highest-volume oncology centres in the country<\/strong>, advancing surgical training and innovation, while continuing to serve as\u00a0a non-profit institution committed to giving back to society<\/strong>. We do not merely practice medicine here. We practice a\u00a0promise<\/strong>, a promise to fight disease with rigour, to restore hope with compassion, and to stand beside every patient with both science and humanity.<\/em><\/p>\n \u00a0<\/em><\/p>\n Shri Nandamuri Balakrishna<\/strong>\u00a0said,\u00a0this conference will be far more than a series of presentations. It will be a\u00a0crucible of ideas<\/strong>\u00a0\u2014 ideas that challenge the way we think, innovations that redefine the way we operate, and collaborations that will carry our field into a future none of us can yet fully imagine. India today stands at a\u00a0defining moment in global oncology<\/strong>. The depth of our clinical experience, the scale of our patient volumes, the brilliance of our talent, and the tenacity of our spirit \u2014 these are not just strengths. They are\u00a0responsibilities<\/strong>. We are no longer merely participants in the global medical conversation.\u00a0We are shaping it<\/strong>. And events like ISDE India Edition 2026 are proof of exactly that.<\/em><\/p>\n Esophageal cancer remains a highly aggressive and underdiagnosed malignancy, with India bearing a significant share of the global burden. Linked to risk factors such as tobacco, alcohol, GERD, poor diet, and, in India, hot beverages and malnutrition, the disease is witnessing rising incidence in states like Andhra Pradesh and Telangana, with higher prevalence in the North-East and Kashmir. Treatment spans surgery, chemotherapy, radiotherapy, and targeted or immunotherapy, supported by advances in diagnostics and minimally invasive techniques.<\/p>\n \u00a0<\/em><\/p>\n Smt Nara Brahmani<\/strong>,\u00a0<\/strong>Trust Board Member,\u00a0BIACH&RI;\u00a0said,\u00a0the<\/em>\u00a0Basavatarakam Indo-American Cancer Hospital, was founded with a very clear and compassionate vision inspired by our founder and my beloved grandfather NT Rama Rao garu to make quality cancer care accessible to all, irrespective of their background, social status or economic status. Over the years that vision has evolved into a living mission and that\u2019s what you see 25 years later, combining clinical expertise with empathy, research with responsibility and innovation with inclusivity. As we mark the Silver Jubilee of the Basavatarakam Indo-American Cancer Hospital, I find myself thinking less about where we are today and more about what we need to achieve in the next 25 years. India is at a defining moment in Oncology, we have the clinical volumes and the talent, we have the hunger to learn from the wisdom drawn from several complicated cases and the diverse patients and populations. May\u00a0<\/em>ISDE India Edition 2026<\/em>, inspire meaningful dialogue, foster lasting collaborations and spark innovations that will shape the future of care.\u00a0\u00a0\u00a0<\/em>\u00a0\u00a0\u00a0<\/em><\/p>\n \u00a0<\/em><\/p>\n ISDE India Edition 2026 is a defining moment that strengthens India\u2019s position in the global fight against esophageal cancer by bringing world-class expertise to Hyderabad,<\/em>\u00a0said\u00a0Dr. T. Subramanyeswara Rao<\/strong>, Medical Director & Chief Surgical Oncologist, BIACH & RI and President, IASO. He added,\u00a0we are here with a spirit of enquiry to treat a difficult and dreadful disease, we understand that this disease needs to be treated differently in different parts of the world and that\u2019s why we are all here, hope you will go back better than you were.\u00a0<\/em><\/p>\n \u00a0<\/em><\/p>\n Prof. Lorenzo Ferri<\/strong>,<\/strong>\u00a0<\/strong>President, ISDE & Director, Division of Thoracic & Upper GI Surgery, McGill University, Canada; said,\u00a0our shared objective is clear, to improve outcomes for patients with esophageal cancer, one of the most aggressive malignancies. Its treatment is equally intensive and often toxic, leaving little margin for error but significant scope for improvement. The path forward lies in collaboration, by working together, and openly exchanging ideas and experiences, we can meaningfully advance patient care.<\/em><\/p>\n \u00a0<\/em><\/p>\n Dr. C.S. Pramesh<\/strong>,\u00a0<\/strong>Director, Tata Memorial Hospital, Mumbai; said,\u00a0behind every successful organisation is strong leadership that shapes its journey. Basavatarakam Indo-American Cancer Hospital stands as a shining example\u2014since its founding 25 years ago, it has thrived under visionary guidance, and continues to do so with the dynamic leadership of Balakrishna garu and a new generation of leaders.<\/em>\u00a0<\/em>Dr. Subramanyeswara Rao\u2019s legacy lies in building a robust, self-sustaining team over the years. The true mark of his leadership is evident today\u2014the institution runs seamlessly, strengthened by the capable hands of the team he so thoughtfully nurtured.<\/em><\/p>\n \u00a0<\/em><\/p>\n Distinguished Guests\u00a0Shri JSR Prasad<\/strong>,\u00a0<\/strong>Treasurer & Trust Board Member,\u00a0BIACH&RI;\u00a0said,\u00a0hosting of the International Society for Diseases of the Esophagus<\/em>,\u00a0for the first time in India, is a landmark moment for the oncology community in India. This has been earned by the country through its decades of relentless clinical work and sheer scale of outpatient experience. Today the world\u2019s most respected medical societies now look to us as leaders in the domain. Basavatarakam Indo-American Cancer Hospital, has strived through the quarter century to staying true to our founding principle of world class cancer treatment not being a privilege of few, it is a right of every patient in this country deserves. I am proud to say that as a non-profit institution we have achieved all this while continuing to make cancer care accessible to patients regardless of their economic background. The balance between excellence and equity is what defines the spirit behind Basavatarakam Indo-American Cancer Hospital.<\/em><\/p>\n \u00a0<\/em><\/p>\n The conference will spotlight cutting-edge advancements, including minimally invasive and robotic esophagectomy, Endoscopic Submucosal Dissection (ESD) for organ preservation, advanced multimodal therapies, and translational research enabling more precise, targeted treatments.<\/p>\n \u00a0<\/em><\/p>\n The distinguished international faculty includes\u00a0Prof. Lorenzo Ferri<\/strong>, Canada;\u00a0Dr. Ken Kato<\/strong>\u00a0and\u00a0Dr. Hiroyuki Daiko<\/strong>, Japan;\u00a0Dr. Edward Cheong<\/strong>, Singapore;\u00a0Dr. Cuong Duong<\/strong>, Australia; and\u00a0Dr. Steven Lin<\/strong>, USA. Leading Indian experts such as\u00a0Dr. T. Subramanyeswara Rao<\/strong>, along with\u00a0Dr. C.S. Pramesh<\/strong>, will provide perspectives tailored to the Indian context. The conference is poised to play a pivotal role in advancing collaboration, knowledge exchange, and clinical excellence in the fight against esophageal cancer.<\/p>\n Distinguished Guests\u00a0Shri JSR Prasad<\/strong>,\u00a0<\/strong>Treasurer & Trust Board Member,\u00a0BIACH&RI;\u00a0Smt Nara Brahmani<\/strong>,\u00a0<\/strong>Trust Board Member,\u00a0BIACH&RI;\u00a0Prof. Lorenzo Ferri<\/strong>,<\/strong>\u00a0<\/strong>President, ISDE & Director, Division of Thoracic & Upper GI Surgery, McGill University, Canada;\u00a0Dr. C.S. Pramesh<\/strong>,\u00a0<\/strong>Director, Tata Memorial Hospital, Mumbai;\u00a0Dr. T. Subramanyeshwar Rao<\/strong>,\u00a0<\/strong>Medical Director, BIACH&RI; President, IASO; President\u2011Elect, Global Forum of Cancer Surgeons;\u00a0<\/strong>Dr. Senthil Rajappa<\/strong>,\u00a0<\/strong>Head of Medical Oncology,\u00a0BIACH&RI;\u00a0<\/strong>Dr. Ken Kato<\/strong>,\u00a0<\/strong>President-Elect, ISDE & National Cancer Center Hospital, Tokyo, Japan;\u00a0Dr. Steven Lin<\/strong>,\u00a0<\/strong>Radiation Oncologist, MD Anderson, Houston USA;\u00a0Dr. Hiroyuki Daiko<\/strong>,\u00a0<\/strong>Esophageal Surgeon, National Cancer Center Hospital, Tokyo, Japan;\u00a0Dr. Edward Cheong<\/strong>,\u00a0<\/strong>Upper GI Surgeon, Panasia Surgery, Singapore; &\u00a0Dr. Cuong Duong<\/strong>,\u00a0<\/strong>Upper GI Surgeon, Peter MacCallum Cancer Centre, Melbourne, Australia and others\u00a0graced the inauguration.<\/p>\n The\u00a0Basavatarakam Indo-American Cancer Hospital & Research Institute<\/strong>, Hyderabad, is a not-for-profit cancer hospital dedicated to delivering evidence-based, world-class oncology care at affordable costs to the Indian population. Over 25 years, it has grown into one of India’s highest-volume cancer centres \u2014 combining clinical excellence, cutting-edge research, and a deep commitment to training the next generation of oncologists.<\/p>\n The\u00a0International Society for Diseases of the Oesophagus (ISDE)<\/strong>\u00a0is a globally respected scientific organisation dedicated to advancing research, education, and clinical practice in the field of oesophageal diseases. Its conferences bring together the world’s leading surgeons, oncologists, and researchers to shape the future of oesophageal cancer care.<\/p>\n Featured Article<\/p>\n","protected":false},"excerpt":{"rendered":" Basavatarakam Indo-American Cancer Hospital & Research Institute, commemorates its silver Jubilee on the occasion. \u00a0 The Conference is jointly hosted by the International Society for Diseases of the Esophagus & Basavatarakam Indo-American Cancer Hospital & Research Institute. \u00a0 Hyderabad, April 10, 2026:\u00a0The prestigious two-day international conference,\u00a0ISDE India Edition 2026,\u00a0hosted by the\u00a0International Society for Diseases of …<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[131],"tags":[32335,32337,32350,32336],"class_list":["post-66865","post","type-post","status-publish","format-standard","","category-regional","tag-basavatarakam-indo-american-cancer-hospital-research-institute","tag-biachri","tag-international-society-for-diseases-of-the-oesophagus","tag-isde"],"yoast_head":"\nAbout BIACH&RI<\/strong><\/h2>\n
About ISDE<\/strong><\/h2>\n